dr. wakelee on available treatments following tumor progression in lung cancer
Published 6 years ago • 208 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:33
dr. wakelee on continued maintenance in lung cancer
-
1:40
dr. wakelee on immediate therapy options in lung cancer
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
1:23
dr. wakelee on veristrat testing in non-small cell lung cancer
-
1:27
dr. wakelee discusses egfr tkis in lung cancer
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
1:46
dr. wakelee on single-agent immunotherapy in nsclc
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:21
dr. wakelee on importance of ngs testing in nsclc
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
1:05
dr. wakelee on recent advancements in egfr-mutant nsclc
-
1:26
dr. wakelee on explaining adjuvant therapy benefits to patients
-
1:55
dr. heather wakelee discusses nintedanib plus chemotherapy in nsclc
-
1:54
dr. wakelee on fda approval of frontline pembrolizumab in nsclc
-
1:19
dr. wakelee on combining targeted agents for the treatment of lung cancer
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc